Chinook Therapeutics Inc. (KDNY) NASDAQ
$40.39 - (-)
Market Cap: -
As of 08/10/23 12:00 AM EDT. Market closed.
Chinook Therapeutics Inc. (KDNY)
NASDAQ
$40.39
- (-)
Market Cap: -
As of 08/10/23 12:00 AM EDT. Market closed.
chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater ... read more
chinook therapeutics (nasdaq: kdny) is a clinical-stage biotechnology company developing precision medicines for kidney diseases. kidney diseases are a severe and growing problem worldwide, with a lack of effective treatments often leading to dialysis, transplantation and high costs to health care systems. drug development in kidney diseases is experiencing a resurgence due to greater understanding of disease biology, utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
King Andrew James | Chief Scientific Officer | Aug 01, 2023 | Sale | $39.03 | 1,168 | 45,586 | 19,157 | Aug 01, 2023, 07:27 PM |
Greenman William Mariner | Director | May 30, 2023 | Sale | $23.30 | 1,155 | 26,911 | 23,643 | May 31, 2023, 07:26 PM |
DOBMEIER ERIC | President, CEO | Apr 24, 2023 | Option Exercise | $0.42 | 25,000 | 10,500 | 326,138 | Apr 26, 2023, 05:19 PM |
DOBMEIER ERIC | President, CEO | Apr 24, 2023 | Sale | $21.61 | 25,000 | 540,239 | 302,338 | Apr 26, 2023, 05:19 PM |
Jerel Davis | Director | Apr 17, 2023 | Sale | $20.75 | 295,808 | 6,138,223 | 443,713 | Apr 19, 2023, 05:58 PM |
King Andrew James | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $0.35 | 2,500 | 875 | 21,992 | Apr 05, 2023, 04:43 PM |
King Andrew James | Chief Scientific Officer | Apr 03, 2023 | Sale | $23.34 | 5,000 | 116,718 | 16,992 | Apr 05, 2023, 04:43 PM |
Krishnan Mahesh | Director | Apr 04, 2023 | Sale | $23.01 | 924 | 21,261 | 1,275 | Apr 04, 2023, 09:14 PM |
Jerel Davis | Director | Mar 01, 2023 | Sale | $22.75 | 400,000 | 9,100,000 | 2,105,107 | Mar 03, 2023, 04:13 PM |
BJERKHOLT ERIC | Chief Financial Officer | Feb 10, 2023 | Sale | $23.75 | 857 | 20,352 | 38,867 | Feb 15, 2023, 04:41 PM |
DOBMEIER ERIC | President, CEO | Feb 10, 2023 | Sale | $23.75 | 8,097 | 192,292 | 301,138 | Feb 15, 2023, 04:40 PM |
Frohlich Tom | Chief Operating Officer | Feb 10, 2023 | Sale | $23.75 | 3,700 | 87,869 | 150,777 | Feb 15, 2023, 04:40 PM |
King Andrew James | Chief Scientific Officer | Feb 10, 2023 | Sale | $23.75 | 2,392 | 56,806 | 19,492 | Feb 15, 2023, 04:39 PM |
Frohlich Tom | Chief Operating Officer | Jan 31, 2023 | Sale | $24.68 | 4,566 | 112,700 | 147,674 | Feb 02, 2023, 06:15 PM |
BJERKHOLT ERIC | Chief Financial Officer | Jan 31, 2023 | Sale | $24.68 | 2,891 | 71,357 | 37,289 | Feb 02, 2023, 06:14 PM |
King Andrew James | Chief Scientific Officer | Jan 31, 2023 | Sale | $24.68 | 3,244 | 80,069 | 15,081 | Feb 02, 2023, 06:13 PM |
DOBMEIER ERIC | President, CEO | Jan 30, 2023 | Option Exercise | $0.42 | 25,000 | 10,500 | 296,676 | Feb 01, 2023, 08:32 PM |
DOBMEIER ERIC | President, CEO | Jan 31, 2023 | Sale | $24.68 | 7,688 | 189,757 | 288,987 | Feb 01, 2023, 08:32 PM |
DOBMEIER ERIC | President, CEO | Jan 30, 2023 | Sale | $24.54 | 25,000 | 613,613 | 271,676 | Feb 01, 2023, 08:32 PM |
King Andrew James | Chief Scientific Officer | Jan 03, 2023 | Option Exercise | $0.35 | 7,500 | 2,625 | 19,992 | Jan 04, 2023, 07:44 PM |
King Andrew James | Chief Scientific Officer | Jan 03, 2023 | Sale | $25.82 | 10,000 | 258,183 | 9,992 | Jan 04, 2023, 07:44 PM |
Frohlich Tom | Chief Operating Officer | Dec 13, 2022 | Option Exercise | $0.42 | 10,000 | 4,200 | 153,907 | Dec 15, 2022, 04:28 PM |
Frohlich Tom | Chief Operating Officer | Dec 13, 2022 | Sale | $25.00 | 10,000 | 250,005 | 143,907 | Dec 15, 2022, 04:28 PM |
DOBMEIER ERIC | President, CEO | Dec 14, 2022 | Option Exercise | $0.35 | 30,000 | 10,500 | 271,676 | Dec 15, 2022, 04:27 PM |
DOBMEIER ERIC | President, CEO | Dec 01, 2022 | Option Exercise | $0.42 | 60,000 | 25,200 | 271,676 | Dec 02, 2022, 04:26 PM |
DOBMEIER ERIC | President, CEO | Dec 01, 2022 | Sale | $22.31 | 30,000 | 669,351 | 241,676 | Dec 02, 2022, 04:26 PM |
BJERKHOLT ERIC | Chief Financial Officer | Dec 01, 2022 | Sale | $22.29 | 5,770 | 128,602 | 32,847 | Dec 02, 2022, 04:25 PM |
Frohlich Tom | Chief Operating Officer | Nov 07, 2022 | Option Exercise | $0.42 | 10,000 | 4,200 | 153,907 | Nov 09, 2022, 04:21 PM |
Frohlich Tom | Chief Operating Officer | Nov 07, 2022 | Sale | $22.16 | 10,000 | 221,642 | 143,907 | Nov 09, 2022, 04:21 PM |
Frohlich Tom | Chief Operating Officer | Oct 06, 2022 | Sale | $19.69 | 7,360 | 144,933 | 143,907 | Oct 11, 2022, 04:33 PM |
King Andrew James | Chief Scientific Officer | Oct 06, 2022 | Sale | $19.69 | 3,557 | 70,044 | 12,492 | Oct 11, 2022, 04:32 PM |
Thomas Dolca | Director | Sep 02, 2022 | Buy | $21.22 | 10,000 | 212,194 | 10,000 | Sep 06, 2022, 04:35 PM |
King Andrew James | Chief Scientific Officer | Aug 04, 2022 | Option Exercise | $0.35 | 5,000 | 1,750 | 10,897 | Aug 05, 2022, 05:09 PM |
King Andrew James | Chief Scientific Officer | Aug 04, 2022 | Sale | $20.00 | 5,000 | 100,000 | 5,897 | Aug 05, 2022, 05:09 PM |
King Andrew James | Chief Scientific Officer | Jul 11, 2022 | Option Exercise | $0.35 | 5,000 | 1,750 | 10,897 | Jul 13, 2022, 04:11 PM |
King Andrew James | Chief Scientific Officer | Jul 11, 2022 | Sale | $18.09 | 5,000 | 90,468 | 5,897 | Jul 13, 2022, 04:11 PM |
AKKARAJU SRINIVAS | Director | May 27, 2022 | Buy | $14.00 | 570,000 | 7,980,000 | 5,161,888 | Jun 01, 2022, 04:13 PM |
DOBMEIER ERIC | President, CEO | May 25, 2022 | Buy | $13.03 | 5,000 | 65,148 | 205,880 | May 27, 2022, 06:17 PM |
King Andrew James | Chief Scientific Officer | Apr 11, 2022 | Option Exercise | $0.35 | 5,000 | 1,750 | 10,897 | Apr 13, 2022, 05:34 PM |
King Andrew James | Chief Scientific Officer | Apr 11, 2022 | Sale | $15.36 | 5,000 | 76,812 | 5,897 | Apr 13, 2022, 05:34 PM |
King Andrew James | Chief Scientific Officer | Feb 18, 2022 | Sale | $13.00 | 2,500 | 32,500 | 5,897 | Feb 23, 2022, 05:17 PM |
BJERKHOLT ERIC | Chief Financial Officer | Feb 11, 2022 | Sale | $12.74 | 895 | 11,403 | 22,203 | Feb 14, 2022, 07:58 PM |
King Andrew James | Chief Scientific Officer | Feb 11, 2022 | Sale | $12.74 | 2,498 | 31,827 | 8,397 | Feb 14, 2022, 07:56 PM |
Glicklich Alan | Chief Medical Officer | Feb 11, 2022 | Sale | $12.74 | 2,391 | 30,464 | 7,891 | Feb 14, 2022, 07:56 PM |
Frohlich Tom | Chief Operating Officer | Feb 11, 2022 | Sale | $12.74 | 3,735 | 47,587 | 137,685 | Feb 14, 2022, 07:53 PM |
King Andrew James | Chief Scientific Officer | Feb 10, 2022 | Option Exercise | $0.35 | 2,500 | 875 | 6,594 | Feb 11, 2022, 05:26 PM |
King Andrew James | Chief Scientific Officer | Feb 10, 2022 | Sale | $13.31 | 2,500 | 33,275 | 4,094 | Feb 11, 2022, 05:26 PM |
Versant Venture Capital VII, L.P. | 10% Owner | Jan 03, 2022 | Sale | $16.00 | 400,000 | 6,400,080 | 1,863,197 | Jan 05, 2022, 05:16 PM |
Versant Venture Capital VII, L.P. | 10% Owner | Jan 03, 2022 | Sale | $16.00 | 600,000 | 9,600,120 | 3,623,023 | Jan 05, 2022, 05:16 PM |
Jerel Davis | Director | Jan 03, 2022 | Sale | $16.00 | 1,000,000 | 16,000,200 | 3,623,023 | Jan 05, 2022, 05:13 PM |
DOBMEIER ERIC | President, CEO | Dec 23, 2021 | Option Exercise | $0.35 | 40,000 | 14,000 | 180,633 | Dec 27, 2021, 06:24 PM |
BJERKHOLT ERIC | Chief Financial Officer | Dec 01, 2021 | Option Exercise | $16.02 | 5,750 | 92,097 | 20,664 | Dec 03, 2021, 07:05 PM |
AKKARAJU SRINIVAS | Director | Nov 15, 2021 | Buy | $14.00 | 1,215,000 | 17,010,000 | 4,591,888 | Nov 17, 2021, 12:05 PM |
Frohlich Tom | Chief Operating Officer | Nov 10, 2021 | Sale | $15.48 | 6,230 | 96,440 | 134,619 | Nov 12, 2021, 08:00 PM |
King Andrew James | Chief Scientific Officer | Nov 09, 2021 | Option Exercise | $0.35 | 2,500 | 875 | 9,094 | Nov 12, 2021, 07:59 PM |
King Andrew James | Chief Scientific Officer | Nov 09, 2021 | Sale | $13.53 | 5,000 | 67,660 | 4,094 | Nov 12, 2021, 07:59 PM |
Frohlich Tom | Chief Operating Officer | Nov 05, 2021 | Option Exercise | $0.42 | 15,000 | 6,300 | 174,619 | Nov 09, 2021, 09:40 PM |
Frohlich Tom | Chief Operating Officer | Nov 05, 2021 | Sale | $14.00 | 20,000 | 280,000 | 159,619 | Nov 09, 2021, 09:40 PM |
Frohlich Tom | Chief Operating Officer | Nov 08, 2021 | Sale | $15.17 | 13,770 | 208,938 | 140,849 | Nov 09, 2021, 09:40 PM |
Greenman William Mariner | Director | Oct 21, 2021 | Option Exercise | $2.60 | 1,663 | 4,324 | 21,498 | Oct 22, 2021, 06:47 PM |
Frohlich Tom | Chief Operating Officer | Oct 06, 2021 | Option Exercise | $12.37 | 7,359 | 91,021 | 159,619 | Oct 08, 2021, 06:51 PM |
King Andrew James | Chief Scientific Officer | Oct 06, 2021 | Option Exercise | $12.37 | 3,557 | 43,995 | 6,594 | Oct 08, 2021, 06:48 PM |
Glicklich Alan | Chief Medical Officer | Oct 06, 2021 | Option Exercise | $12.37 | 2,489 | 30,785 | 4,614 | Oct 08, 2021, 06:46 PM |
Frohlich Tom | Chief Operating Officer | Sep 24, 2021 | Option Exercise | $0.42 | 20,000 | 8,400 | 153,398 | Sep 28, 2021, 04:46 PM |
Frohlich Tom | Chief Operating Officer | Sep 24, 2021 | Sale | $13.00 | 20,000 | 260,000 | 133,398 | Sep 24, 2021, 08:16 PM |
DOBMEIER ERIC | President, CEO | Sep 20, 2021 | Buy | $12.00 | 2,000 | 24,000 | 109,837 | Sep 22, 2021, 07:23 PM |
Jerel Davis | Director | Aug 27, 2021 | Sale | $14.00 | 850,000 | 11,900,000 | 4,223,023 | Aug 31, 2021, 07:06 PM |
Versant Venture Capital VII, L.P. | 10% Owner | Aug 27, 2021 | Sale | $14.00 | 340,000 | 4,760,000 | 2,171,197 | Aug 31, 2021, 07:06 PM |
Versant Venture Capital VII, L.P. | 10% Owner | Aug 27, 2021 | Sale | $14.00 | 510,000 | 7,140,000 | 4,223,023 | Aug 31, 2021, 07:06 PM |
AKKARAJU SRINIVAS | Director | Aug 18, 2021 | Buy | $11.98 | 208,500 | 2,497,830 | 3,376,888 | Aug 20, 2021, 05:37 PM |
DOBMEIER ERIC | President, CEO | Aug 19, 2021 | Buy | $12.00 | 3,000 | 36,000 | 107,837 | Aug 19, 2021, 05:55 PM |
DOBMEIER ERIC | President, CEO | Aug 18, 2021 | Buy | $11.74 | 7,000 | 82,163 | 104,837 | Aug 19, 2021, 05:55 PM |
Glicklich Alan | Chief Medical Officer | Jun 16, 2021 | Option Exercise | $0.42 | 20,000 | 8,400 | 20,000 | Jun 17, 2021, 06:40 PM |
Glicklich Alan | Chief Medical Officer | Jun 16, 2021 | Sale | $16.35 | 20,000 | 326,968 | 0 | Jun 17, 2021, 06:40 PM |
DOBMEIER ERIC | President, CEO | Jun 14, 2021 | Option Exercise | $0.35 | 20,000 | 7,000 | 97,837 | Jun 15, 2021, 05:24 PM |
DOBMEIER ERIC | President, CEO | Dec 21, 2020 | Option Exercise | $0.35 | 20,000 | 7,000 | 76,837 | Dec 22, 2020, 07:47 PM |
DOBMEIER ERIC | President, CEO | Dec 09, 2020 | Buy | $13.07 | 2,000 | 26,150 | 56,837 | Dec 10, 2020, 05:38 PM |
DOBMEIER ERIC | President, CEO | Dec 08, 2020 | Buy | $13.24 | 2,000 | 26,483 | 54,837 | Dec 10, 2020, 05:38 PM |
DOBMEIER ERIC | President, CEO | Nov 23, 2020 | Buy | $13.67 | 929 | 12,699 | 52,837 | Nov 23, 2020, 07:26 PM |
DOBMEIER ERIC | President, CEO | Nov 20, 2020 | Buy | $13.69 | 571 | 7,817 | 51,908 | Nov 23, 2020, 07:26 PM |
DOBMEIER ERIC | President, CEO | Nov 19, 2020 | Buy | $13.50 | 500 | 6,750 | 51,337 | Nov 23, 2020, 07:26 PM |
DOBMEIER ERIC | President, CEO | Nov 11, 2020 | Buy | $13.75 | 2,500 | 34,375 | 50,837 | Nov 13, 2020, 06:13 PM |
DOBMEIER ERIC | President, CEO | Nov 10, 2020 | Buy | $13.86 | 2,000 | 27,720 | 48,337 | Nov 13, 2020, 06:13 PM |
ISAACS STEPHEN T | President and CEO | Sep 15, 2020 | Sale | $2.39 | 32,481 | 77,691 | 279,166 | Sep 17, 2020, 08:17 PM |
Templeman Blaine | Chief Legal Officer | Sep 15, 2020 | Sale | $2.39 | 12,369 | 29,585 | 121,916 | Sep 17, 2020, 08:16 PM |
Ferber Celeste | SVP, GC and Secretary | Sep 15, 2020 | Sale | $2.39 | 2,396 | 5,731 | 38,687 | Sep 17, 2020, 08:15 PM |
Nuyten Dimitry SA | Chief Medical Officer | Aug 07, 2020 | Sale | $2.55 | 3,538 | 9,036 | 8,462 | Aug 11, 2020, 04:06 PM |
Templeman Blaine | Chief Legal Officer | Aug 07, 2020 | Sale | $2.55 | 7,951 | 20,308 | 134,285 | Aug 11, 2020, 04:05 PM |
Ferber Celeste | SVP, GC and Secretary | Aug 07, 2020 | Sale | $2.55 | 7,951 | 20,308 | 41,083 | Aug 11, 2020, 04:04 PM |
Greenman William Mariner | Director | Mar 18, 2020 | Option Exercise | $0.45 | 19,835 | 8,926 | 19,835 | Mar 20, 2020, 05:18 PM |
ISAACS STEPHEN T | President and CEO | Mar 18, 2020 | Option Exercise | $0.45 | 21,618 | 9,728 | 311,647 | Mar 20, 2020, 05:17 PM |
van Elsas Andrea | Chief Scientific Officer | Feb 25, 2020 | Sale | $3.51 | 6,823 | 23,954 | 438,367 | Feb 26, 2020, 06:58 PM |
van Elsas Andrea | Chief Scientific Officer | Jan 03, 2020 | Sale | $1.19 | 73,311 | 87,108 | 445,190 | Jan 06, 2020, 06:38 PM |
Templeman Blaine | Chief Legal Officer | Dec 12, 2019 | Sale | $1.16 | 1,264 | 1,470 | 117,736 | Dec 16, 2019, 04:14 PM |
Ferber Celeste | SVP, GC and Secretary | Dec 12, 2019 | Sale | $1.16 | 408 | 475 | 26,534 | Dec 16, 2019, 04:13 PM |
van Elsas Andrea | Chief Scientific Officer | Dec 12, 2019 | Sale | $1.16 | 2,192 | 2,550 | 518,501 | Dec 16, 2019, 04:13 PM |
ISAACS STEPHEN T | President and CEO | Dec 12, 2019 | Sale | $1.16 | 5,897 | 6,860 | 290,029 | Dec 16, 2019, 04:12 PM |
Haghighat Ross | Director | Sep 16, 2019 | Option Exercise | $0.64 | 55,539 | 35,527 | 87,122 | Sep 18, 2019, 07:00 PM |
Ferber Celeste | SVP, GC and Secretary | Sep 13, 2019 | Sale | $1.31 | 2,494 | 3,257 | 28,044 | Sep 17, 2019, 06:34 PM |
ISAACS STEPHEN T | President and CEO | Sep 13, 2019 | Sale | $1.31 | 31,098 | 40,608 | 295,926 | Sep 17, 2019, 06:34 PM |
van Elsas Andrea | Chief Scientific Officer | Sep 13, 2019 | Sale | $1.31 | 18,593 | 24,279 | 521,327 | Sep 17, 2019, 06:33 PM |
Templeman Blaine | Chief Legal Officer | Sep 13, 2019 | Sale | $1.31 | 12,878 | 16,817 | 122,888 | Sep 17, 2019, 06:32 PM |
Ferber Celeste | SVP, GC and Secretary | May 20, 2019 | Sale | $3.21 | 2,000 | 6,413 | 29,436 | May 22, 2019, 07:04 PM |
Lew Jennifer | Chief Financial Officer | May 01, 2019 | Option Exercise | $1.25 | 18,602 | 23,306 | 147,299 | May 03, 2019, 07:17 PM |
Lew Jennifer | Chief Financial Officer | May 01, 2019 | Sale | $4.20 | 18,602 | 78,136 | 135,155 | May 03, 2019, 07:17 PM |
Lew Jennifer | Chief Financial Officer | Apr 08, 2019 | Option Exercise | $1.25 | 18,601 | 23,305 | 147,299 | Apr 10, 2019, 07:09 PM |
Lew Jennifer | Chief Financial Officer | Apr 08, 2019 | Sale | $4.07 | 18,601 | 75,775 | 135,155 | Apr 10, 2019, 07:09 PM |
van Elsas Andrea | Chief Scientific Officer | Mar 19, 2019 | Sale | $3.96 | 6,081 | 24,107 | 239,557 | Mar 21, 2019, 05:35 PM |
van Elsas Andrea | Chief Scientific Officer | Feb 26, 2019 | Sale | $4.25 | 6,844 | 29,120 | 245,638 | Feb 27, 2019, 07:07 PM |
van Elsas Andrea | Chief Scientific Officer | Dec 28, 2018 | Sale | $2.57 | 1,907 | 4,901 | 252,482 | Dec 31, 2018, 04:02 PM |
Lew Jennifer | Chief Financial Officer | Dec 12, 2018 | Sale | $2.93 | 1,035 | 3,035 | 135,155 | Dec 14, 2018, 04:19 PM |
Templeman Blaine | Chief Legal Officer | Dec 12, 2018 | Sale | $2.93 | 1,241 | 3,639 | 129,878 | Dec 14, 2018, 04:18 PM |
ISAACS STEPHEN T | President and CEO | Dec 12, 2018 | Sale | $2.93 | 5,829 | 17,091 | 327,024 | Dec 14, 2018, 04:17 PM |
van Elsas Andrea | Chief Scientific Officer | Dec 12, 2018 | Sale | $2.93 | 2,171 | 6,365 | 254,389 | Dec 14, 2018, 04:15 PM |
Templeman Blaine | Chief Legal Officer | Nov 20, 2018 | Sale | $2.91 | 843 | 2,453 | 131,119 | Nov 20, 2018, 07:58 PM |
van Elsas Andrea | Chief Scientific Officer | Sep 24, 2018 | Sale | $5.83 | 7,726 | 45,022 | 256,560 | Sep 25, 2018, 08:11 PM |
Templeman Blaine | Chief Legal Officer | Sep 24, 2018 | Sale | $5.81 | 10,262 | 59,613 | 131,119 | Sep 25, 2018, 08:10 PM |
Templeman Blaine | Executive VP, General Counsel | Sep 13, 2018 | Sale | $6.50 | 6,056 | 39,360 | 141,381 | Sep 14, 2018, 07:29 PM |
van Elsas Andrea | Chief Scientific Officer | Sep 13, 2018 | Sale | $6.50 | 9,754 | 63,394 | 264,286 | Sep 14, 2018, 07:28 PM |
Lew Jennifer | Chief Financial Officer | Sep 13, 2018 | Sale | $6.50 | 5,623 | 36,546 | 136,190 | Sep 14, 2018, 07:27 PM |
Sacks Natalie | Chief Medical Officer | Sep 13, 2018 | Sale | $6.50 | 3,028 | 19,680 | 173,720 | Sep 14, 2018, 07:25 PM |
ISAACS STEPHEN T | President and CEO | Sep 13, 2018 | Sale | $6.50 | 24,143 | 156,913 | 332,853 | Sep 14, 2018, 07:24 PM |
ISAACS STEPHEN T | President and CEO | Sep 06, 2018 | Option Exercise | $1.00 | 46,987 | 46,987 | 252,733 | Sep 06, 2018, 07:42 PM |
ISAACS STEPHEN T | President and CEO | Sep 05, 2018 | Option Exercise | $1.00 | 15,585 | 15,585 | 221,331 | Sep 06, 2018, 07:42 PM |
ISAACS STEPHEN T | President and CEO | Sep 06, 2018 | Sale | $7.92 | 46,987 | 372,024 | 205,746 | Sep 06, 2018, 07:42 PM |
ISAACS STEPHEN T | President and CEO | Sep 05, 2018 | Sale | $7.90 | 15,585 | 123,134 | 205,746 | Sep 06, 2018, 07:42 PM |
Sacks Natalie | Chief Medical Officer | Sep 04, 2018 | Sale | $7.13 | 4,504 | 32,099 | 89,548 | Sep 06, 2018, 07:40 PM |
van Elsas Andrea | Chief Scientific Officer | Jul 17, 2018 | Sale | $6.96 | 10,454 | 72,803 | 206,215 | Jul 19, 2018, 07:39 PM |
ISAACS STEPHEN T | President and CEO | Jun 01, 2018 | Option Exercise | $1.00 | 40,000 | 40,000 | 245,746 | Jun 05, 2018, 08:58 PM |
ISAACS STEPHEN T | President and CEO | Jun 01, 2018 | Sale | $8.68 | 40,000 | 347,004 | 205,746 | Jun 05, 2018, 08:58 PM |
Templeman Blaine | Chief Legal Officer | May 17, 2018 | Sale | $8.15 | 2,000 | 16,300 | 69,937 | May 21, 2018, 06:25 PM |
ISAACS STEPHEN T | President and CEO | May 09, 2018 | Option Exercise | $0.97 | 40,000 | 38,976 | 245,746 | May 11, 2018, 05:00 PM |
ISAACS STEPHEN T | President and CEO | May 09, 2018 | Sale | $8.01 | 40,000 | 320,348 | 205,746 | May 11, 2018, 05:00 PM |
ISAACS STEPHEN T | President and CEO | Apr 02, 2018 | Option Exercise | $0.82 | 40,000 | 32,800 | 245,746 | Apr 04, 2018, 06:26 PM |
ISAACS STEPHEN T | President and CEO | Apr 02, 2018 | Sale | $8.91 | 40,000 | 356,400 | 205,746 | Apr 04, 2018, 06:26 PM |
ISAACS STEPHEN T | President and CEO | Mar 09, 2018 | Option Exercise | $0.50 | 46,417 | 23,165 | 252,163 | Mar 09, 2018, 07:40 PM |
ISAACS STEPHEN T | President and CEO | Mar 08, 2018 | Option Exercise | $0.45 | 25,634 | 11,535 | 231,380 | Mar 09, 2018, 07:40 PM |
ISAACS STEPHEN T | President and CEO | Mar 09, 2018 | Sale | $8.77 | 46,417 | 407,268 | 226,351 | Mar 09, 2018, 07:40 PM |
ISAACS STEPHEN T | President and CEO | Mar 08, 2018 | Sale | $7.95 | 25,634 | 203,790 | 205,746 | Mar 09, 2018, 07:40 PM |
van Elsas Andrea | Chief Scientific Officer | Feb 26, 2018 | Sale | $6.48 | 6,874 | 44,522 | 216,669 | Feb 27, 2018, 06:56 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jan 25, 2018 | Option Exercise | $0.82 | 60,000 | 49,200 | 250,745 | Jan 26, 2018, 07:15 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jan 25, 2018 | Option Exercise | $0.01 | 3,317 | 33 | 254,062 | Jan 26, 2018, 07:15 PM |
ISAACS STEPHEN T | President and CEO | Jan 05, 2018 | Option Exercise | $0.45 | 7,949 | 3,577 | 213,695 | Jan 09, 2018, 05:48 PM |
ISAACS STEPHEN T | President and CEO | Jan 05, 2018 | Sale | $7.95 | 7,949 | 63,195 | 205,746 | Jan 09, 2018, 05:48 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Dec 29, 2017 | Option Exercise | $1.45 | 52,000 | 75,400 | 124,603 | Jan 03, 2018, 07:03 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jan 02, 2018 | Option Exercise | $1.04 | 20,000 | 20,767 | 210,745 | Jan 03, 2018, 06:59 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 29, 2017 | Option Exercise | $0.82 | 42,000 | 34,440 | 190,745 | Jan 03, 2018, 06:59 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jan 02, 2018 | Sale | $7.61 | 20,000 | 152,142 | 190,745 | Jan 03, 2018, 06:59 PM |
Templeman Blaine | Executive VP, General Counsel | Dec 18, 2017 | Sale | $8.25 | 2,884 | 23,793 | 69,937 | Dec 20, 2017, 06:52 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Dec 15, 2017 | Option Exercise | $1.45 | 64,108 | 92,957 | 137,826 | Dec 15, 2017, 08:02 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Dec 15, 2017 | Sale | $8.11 | 65,223 | 529,187 | 72,603 | Dec 15, 2017, 08:02 PM |
van Elsas Andrea | Chief Scientific Officer | Sep 13, 2017 | Sale | $10.99 | 4,922 | 54,072 | 202,581 | Dec 15, 2017, 07:58 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Dec 01, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 83,718 | Dec 04, 2017, 07:59 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Dec 01, 2017 | Sale | $9.40 | 10,000 | 93,998 | 73,718 | Dec 04, 2017, 07:59 PM |
Lew Jennifer | Sr. Vice President of Finance | Dec 01, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 68,938 | Dec 04, 2017, 07:57 PM |
Lew Jennifer | Sr. Vice President of Finance | Dec 01, 2017 | Sale | $9.46 | 6,600 | 62,433 | 62,338 | Dec 04, 2017, 07:57 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 01, 2017 | Option Exercise | $1.04 | 20,000 | 20,767 | 168,745 | Dec 04, 2017, 07:56 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 01, 2017 | Sale | $9.34 | 20,000 | 186,882 | 148,745 | Dec 04, 2017, 07:56 PM |
ISAACS STEPHEN T | President and CEO | Dec 01, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 213,921 | Dec 04, 2017, 07:53 PM |
ISAACS STEPHEN T | President and CEO | Dec 01, 2017 | Sale | $9.38 | 40,000 | 375,028 | 173,921 | Dec 04, 2017, 07:53 PM |
Templeman Blaine | Executive VP, General Counsel | Nov 17, 2017 | Sale | $8.85 | 243 | 2,151 | 58,834 | Nov 17, 2017, 06:43 PM |
Lew Jennifer | Sr. Vice President of Finance | Nov 15, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 68,938 | Nov 17, 2017, 06:42 PM |
Lew Jennifer | Sr. Vice President of Finance | Nov 15, 2017 | Sale | $8.95 | 6,600 | 59,070 | 62,338 | Nov 17, 2017, 06:42 PM |
ISAACS STEPHEN T | President and CEO | Nov 13, 2017 | Option Exercise | $0.45 | 3,400 | 1,530 | 177,321 | Nov 14, 2017, 06:20 PM |
ISAACS STEPHEN T | President and CEO | Nov 10, 2017 | Option Exercise | $0.45 | 16,400 | 7,380 | 190,321 | Nov 14, 2017, 06:20 PM |
ISAACS STEPHEN T | President and CEO | Nov 13, 2017 | Sale | $8.00 | 3,400 | 27,215 | 173,921 | Nov 14, 2017, 06:20 PM |
ISAACS STEPHEN T | President and CEO | Nov 10, 2017 | Sale | $7.96 | 16,400 | 130,508 | 173,921 | Nov 14, 2017, 06:20 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Nov 13, 2017 | Option Exercise | $0.52 | 4,062 | 2,112 | 77,780 | Nov 14, 2017, 06:09 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Nov 10, 2017 | Option Exercise | $0.52 | 1,815 | 944 | 75,533 | Nov 14, 2017, 06:09 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Nov 13, 2017 | Sale | $8.00 | 4,062 | 32,496 | 73,718 | Nov 14, 2017, 06:09 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Nov 10, 2017 | Sale | $8.01 | 1,815 | 14,544 | 73,718 | Nov 14, 2017, 06:09 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 06, 2017 | Option Exercise | $1.04 | 20,000 | 20,767 | 168,745 | Nov 08, 2017, 08:01 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 06, 2017 | Sale | $7.97 | 20,000 | 159,312 | 148,745 | Nov 08, 2017, 08:01 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Nov 06, 2017 | Option Exercise | $0.52 | 4,123 | 2,144 | 77,841 | Nov 08, 2017, 07:59 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Nov 06, 2017 | Sale | $8.04 | 4,123 | 33,132 | 73,718 | Nov 08, 2017, 07:59 PM |
ISAACS STEPHEN T | President and CEO | Nov 07, 2017 | Option Exercise | $0.45 | 3,800 | 1,710 | 177,721 | Nov 08, 2017, 07:56 PM |
ISAACS STEPHEN T | President and CEO | Nov 06, 2017 | Option Exercise | $0.45 | 16,400 | 7,380 | 190,321 | Nov 08, 2017, 07:56 PM |
ISAACS STEPHEN T | President and CEO | Nov 07, 2017 | Sale | $7.95 | 3,800 | 30,223 | 173,921 | Nov 08, 2017, 07:56 PM |
ISAACS STEPHEN T | President and CEO | Nov 06, 2017 | Sale | $7.98 | 16,400 | 130,934 | 173,921 | Nov 08, 2017, 07:56 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Oct 02, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 83,718 | Oct 04, 2017, 08:31 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Oct 02, 2017 | Sale | $10.59 | 10,000 | 105,870 | 73,718 | Oct 04, 2017, 08:31 PM |
SCHAFER GREGORY W | Chief Operating Officer | Oct 02, 2017 | Option Exercise | $1.36 | 20,000 | 27,148 | 168,745 | Oct 04, 2017, 08:26 PM |
SCHAFER GREGORY W | Chief Operating Officer | Oct 02, 2017 | Sale | $10.75 | 20,000 | 215,060 | 148,745 | Oct 04, 2017, 08:26 PM |
ISAACS STEPHEN T | President and CEO | Oct 02, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 213,921 | Oct 04, 2017, 08:23 PM |
ISAACS STEPHEN T | President and CEO | Oct 02, 2017 | Sale | $10.78 | 40,000 | 431,032 | 173,921 | Oct 04, 2017, 08:23 PM |
Lew Jennifer | Sr. Vice President of Finance | Oct 02, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 68,938 | Oct 04, 2017, 08:21 PM |
Lew Jennifer | Sr. Vice President of Finance | Oct 02, 2017 | Sale | $10.61 | 6,600 | 69,995 | 62,338 | Oct 04, 2017, 08:21 PM |
Templeman Blaine | Executive VP, General Counsel | Sep 18, 2017 | Sale | $11.20 | 2,884 | 32,301 | 58,834 | Sep 20, 2017, 07:11 PM |
ISAACS STEPHEN T | President and CEO | Sep 13, 2017 | Sale | $10.99 | 12,204 | 134,071 | 173,921 | Sep 14, 2017, 09:25 PM |
SCHAFER GREGORY W | Chief Operating Officer | Sep 13, 2017 | Sale | $10.99 | 4,859 | 53,380 | 148,745 | Sep 14, 2017, 09:24 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Sep 13, 2017 | Sale | $10.99 | 3,557 | 39,076 | 73,718 | Sep 14, 2017, 09:22 PM |
Lew Jennifer | Sr. Vice President of Finance | Sep 13, 2017 | Sale | $10.99 | 3,557 | 39,076 | 62,338 | Sep 14, 2017, 09:21 PM |
van Elsas Andrea | Chief Scientific Officer | Sep 13, 2017 | Sale | $10.99 | 4,922 | 54,072 | 207,231 | Sep 14, 2017, 09:20 PM |
Templeman Blaine | Executive VP, General Counsel | Sep 13, 2017 | Sale | $10.99 | 3,557 | 39,076 | 61,718 | Sep 14, 2017, 09:19 PM |
Sacks Natalie | Chief Medical Officer | Sep 01, 2017 | Sale | $11.71 | 4,885 | 57,196 | 45,115 | Sep 06, 2017, 04:32 PM |
SCHAFER GREGORY W | Chief Operating Officer | Sep 01, 2017 | Option Exercise | $1.24 | 20,000 | 24,800 | 140,979 | Sep 06, 2017, 04:30 PM |
SCHAFER GREGORY W | Chief Operating Officer | Sep 01, 2017 | Sale | $11.70 | 20,000 | 233,980 | 120,979 | Sep 06, 2017, 04:30 PM |
Lew Jennifer | Sr. Vice President of Finance | Sep 01, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 49,195 | Sep 06, 2017, 04:29 PM |
Lew Jennifer | Sr. Vice President of Finance | Sep 01, 2017 | Sale | $11.70 | 6,600 | 77,242 | 42,595 | Sep 06, 2017, 04:29 PM |
ISAACS STEPHEN T | President and CEO | Sep 01, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 144,025 | Sep 06, 2017, 04:28 PM |
ISAACS STEPHEN T | President and CEO | Sep 01, 2017 | Sale | $11.71 | 40,000 | 468,596 | 104,025 | Sep 06, 2017, 04:28 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Sep 01, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 59,300 | Sep 06, 2017, 04:27 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Sep 01, 2017 | Sale | $11.69 | 10,000 | 116,948 | 49,300 | Sep 06, 2017, 04:27 PM |
Dubensky Thomas W. | Chief Scientific Officer | Aug 10, 2017 | Option Exercise | $1.00 | 40,912 | 40,912 | 80,812 | Aug 11, 2017, 08:03 PM |
Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2017 | Option Exercise | $1.00 | 9,088 | 9,088 | 48,988 | Aug 11, 2017, 08:03 PM |
Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2017 | Sale | $11.17 | 9,088 | 101,538 | 39,900 | Aug 11, 2017, 08:03 PM |
Dubensky Thomas W. | Chief Scientific Officer | Aug 10, 2017 | Sale | $11.43 | 40,912 | 467,665 | 39,900 | Aug 11, 2017, 08:03 PM |
ISAACS STEPHEN T | President and CEO | Aug 07, 2017 | Option Exercise | $0.45 | 40,000 | 18,000 | 144,025 | Aug 09, 2017, 07:46 PM |
ISAACS STEPHEN T | President and CEO | Aug 07, 2017 | Sale | $12.19 | 40,000 | 487,564 | 104,025 | Aug 09, 2017, 07:46 PM |
SCHAFER GREGORY W | Chief Operating Officer | Aug 07, 2017 | Option Exercise | $1.22 | 25,811 | 31,616 | 146,790 | Aug 09, 2017, 07:45 PM |
SCHAFER GREGORY W | Chief Operating Officer | Aug 08, 2017 | Option Exercise | $1.27 | 14,189 | 18,004 | 135,168 | Aug 09, 2017, 07:45 PM |
SCHAFER GREGORY W | Chief Operating Officer | Aug 08, 2017 | Sale | $12.16 | 14,189 | 172,550 | 120,979 | Aug 09, 2017, 07:45 PM |
SCHAFER GREGORY W | Chief Operating Officer | Aug 07, 2017 | Sale | $12.17 | 25,811 | 314,233 | 120,979 | Aug 09, 2017, 07:45 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Aug 07, 2017 | Option Exercise | $0.52 | 10,000 | 5,200 | 59,300 | Aug 09, 2017, 07:44 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Aug 07, 2017 | Sale | $12.18 | 10,000 | 121,795 | 49,300 | Aug 09, 2017, 07:44 PM |
Lew Jennifer | Sr. Vice President of Finance | Aug 07, 2017 | Option Exercise | $0.82 | 6,600 | 5,412 | 49,195 | Aug 09, 2017, 07:41 PM |
Lew Jennifer | Sr. Vice President of Finance | Aug 07, 2017 | Sale | $12.17 | 6,600 | 80,290 | 42,595 | Aug 09, 2017, 07:41 PM |
Lew Jennifer | Sr. Vice President of Finance | Jul 03, 2017 | Option Exercise | $0.82 | 12,000 | 9,840 | 54,595 | Jul 06, 2017, 07:13 PM |
Lew Jennifer | Sr. Vice President of Finance | Jul 03, 2017 | Sale | $11.14 | 12,000 | 133,632 | 42,595 | Jul 06, 2017, 07:13 PM |
ISAACS STEPHEN T | President and CEO | Jul 03, 2017 | Option Exercise | $0.50 | 40,000 | 19,965 | 144,025 | Jul 06, 2017, 07:12 PM |
ISAACS STEPHEN T | President and CEO | Jul 05, 2017 | Sale | $11.01 | 1,341 | 14,763 | 104,025 | Jul 06, 2017, 07:12 PM |
ISAACS STEPHEN T | President and CEO | Jul 03, 2017 | Sale | $11.06 | 38,659 | 427,634 | 105,366 | Jul 06, 2017, 07:12 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Jul 03, 2017 | Option Exercise | $0.48 | 10,000 | 4,826 | 59,300 | Jul 06, 2017, 07:11 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Jul 03, 2017 | Sale | $11.02 | 10,000 | 110,167 | 49,300 | Jul 06, 2017, 07:11 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2017 | Option Exercise | $0.52 | 33,688 | 17,518 | 73,588 | Jul 06, 2017, 07:10 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 03, 2017 | Option Exercise | $0.52 | 11,800 | 6,136 | 51,700 | Jul 06, 2017, 07:10 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 06, 2017 | Option Exercise | $0.52 | 4,512 | 2,346 | 44,412 | Jul 06, 2017, 07:10 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2017 | Sale | $11.46 | 33,688 | 385,936 | 39,900 | Jul 06, 2017, 07:10 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 03, 2017 | Sale | $11.02 | 11,800 | 130,028 | 39,900 | Jul 06, 2017, 07:10 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 06, 2017 | Sale | $11.23 | 4,512 | 50,673 | 39,900 | Jul 06, 2017, 07:10 PM |
Lew Jennifer | Sr. Vice President of Finance | Jun 28, 2017 | Option Exercise | $0.82 | 12,000 | 9,840 | 54,595 | Jun 30, 2017, 06:03 PM |
Lew Jennifer | Sr. Vice President of Finance | Jun 28, 2017 | Sale | $11.19 | 12,000 | 134,236 | 42,595 | Jun 30, 2017, 06:03 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jun 28, 2017 | Option Exercise | $1.45 | 40,000 | 58,000 | 160,979 | Jun 30, 2017, 06:01 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jun 28, 2017 | Sale | $11.26 | 40,000 | 450,568 | 120,979 | Jun 30, 2017, 06:01 PM |
ISAACS STEPHEN T | President and CEO | Jun 19, 2017 | Option Exercise | $0.52 | 40,000 | 20,800 | 144,025 | Jun 21, 2017, 06:56 PM |
ISAACS STEPHEN T | President and CEO | Jun 19, 2017 | Sale | $10.50 | 40,000 | 420,164 | 104,025 | Jun 21, 2017, 06:56 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jun 05, 2017 | Option Exercise | $0.52 | 17,577 | 9,140 | 57,477 | Jun 05, 2017, 07:25 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jun 02, 2017 | Option Exercise | $0.52 | 48,753 | 25,352 | 88,653 | Jun 05, 2017, 07:25 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jun 01, 2017 | Option Exercise | $0.52 | 77,971 | 40,545 | 117,871 | Jun 05, 2017, 07:25 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jun 02, 2017 | Sale | $10.10 | 48,753 | 492,283 | 39,900 | Jun 05, 2017, 07:25 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jun 01, 2017 | Sale | $10.00 | 77,971 | 779,866 | 39,900 | Jun 05, 2017, 07:25 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jun 05, 2017 | Sale | $9.99 | 17,577 | 175,628 | 39,900 | Jun 05, 2017, 07:25 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Jun 01, 2017 | Option Exercise | $0.52 | 8,000 | 4,160 | 57,300 | Jun 05, 2017, 07:22 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Jun 01, 2017 | Sale | $10.00 | 8,000 | 80,020 | 49,300 | Jun 05, 2017, 07:22 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | May 17, 2017 | Sale | $9.65 | 1,011 | 9,756 | 49,300 | May 18, 2017, 08:33 PM |
Templeman Blaine | Executive VP, General Counsel | May 17, 2017 | Sale | $9.65 | 1,648 | 15,903 | 37,300 | May 18, 2017, 08:30 PM |
ISAACS STEPHEN T | President and CEO | May 16, 2017 | Option Exercise | $0.52 | 16,673 | 8,670 | 120,698 | May 17, 2017, 05:55 PM |
ISAACS STEPHEN T | President and CEO | May 15, 2017 | Option Exercise | $0.52 | 10,600 | 5,512 | 114,625 | May 17, 2017, 05:55 PM |
ISAACS STEPHEN T | President and CEO | May 16, 2017 | Sale | $10.00 | 16,673 | 166,797 | 104,025 | May 17, 2017, 05:55 PM |
ISAACS STEPHEN T | President and CEO | May 15, 2017 | Sale | $10.01 | 10,600 | 106,154 | 104,025 | May 17, 2017, 05:55 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | May 11, 2017 | Option Exercise | $0.52 | 8,000 | 4,160 | 57,300 | May 15, 2017, 06:57 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | May 11, 2017 | Sale | $9.72 | 8,000 | 77,725 | 49,300 | May 15, 2017, 06:57 PM |
Dubensky Thomas W. | Chief Scientific Officer | May 12, 2017 | Option Exercise | $0.52 | 4,299 | 2,235 | 44,199 | May 15, 2017, 06:56 PM |
Dubensky Thomas W. | Chief Scientific Officer | May 11, 2017 | Option Exercise | $0.52 | 1,400 | 728 | 41,300 | May 15, 2017, 06:56 PM |
Dubensky Thomas W. | Chief Scientific Officer | May 12, 2017 | Sale | $9.92 | 4,299 | 42,658 | 39,900 | May 15, 2017, 06:56 PM |
Dubensky Thomas W. | Chief Scientific Officer | May 11, 2017 | Sale | $9.91 | 1,400 | 13,870 | 39,900 | May 15, 2017, 06:56 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Apr 03, 2017 | Option Exercise | $0.45 | 8,000 | 3,600 | 57,300 | Apr 04, 2017, 08:18 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Apr 03, 2017 | Sale | $10.71 | 8,000 | 85,645 | 49,300 | Apr 04, 2017, 08:18 PM |
ISAACS STEPHEN T | President and CEO | Apr 03, 2017 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Apr 04, 2017, 08:17 PM |
ISAACS STEPHEN T | President and CEO | Apr 03, 2017 | Sale | $10.28 | 27,273 | 280,429 | 102,200 | Apr 04, 2017, 08:17 PM |
ISAACS STEPHEN T | President and CEO | Mar 13, 2017 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Mar 14, 2017, 08:02 PM |
ISAACS STEPHEN T | President and CEO | Mar 13, 2017 | Sale | $11.35 | 27,273 | 309,434 | 102,200 | Mar 14, 2017, 08:02 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Mar 09, 2017 | Option Exercise | $0.45 | 8,000 | 3,600 | 57,300 | Mar 10, 2017, 08:05 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Mar 09, 2017 | Sale | $11.00 | 8,000 | 88,001 | 49,300 | Mar 10, 2017, 08:05 PM |
Dubensky Thomas W. | Chief Scientific Officer | Mar 09, 2017 | Option Exercise | $0.78 | 25,000 | 19,446 | 64,900 | Mar 10, 2017, 08:04 PM |
Dubensky Thomas W. | Chief Scientific Officer | Mar 09, 2017 | Sale | $10.96 | 25,000 | 274,078 | 39,900 | Mar 10, 2017, 08:04 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Jan 17, 2017 | Option Exercise | $0.45 | 8,000 | 3,600 | 57,300 | Jan 19, 2017, 06:52 PM |
Brockstedt Dirk G. | EVP of Research and Dev. | Jan 17, 2017 | Sale | $11.86 | 8,000 | 94,858 | 49,300 | Jan 19, 2017, 06:52 PM |
Templeman Blaine | Executive VP, General Counsel | Jan 11, 2017 | Sale | $11.95 | 3,785 | 45,231 | 37,300 | Jan 13, 2017, 04:33 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jan 03, 2017 | Option Exercise | $0.52 | 25,000 | 13,000 | 64,900 | Jan 05, 2017, 05:15 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jan 03, 2017 | Sale | $11.16 | 25,000 | 278,990 | 39,900 | Jan 05, 2017, 05:15 PM |
ISAACS STEPHEN T | President and CEO | Jan 03, 2017 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Jan 05, 2017, 05:14 PM |
ISAACS STEPHEN T | President and CEO | Jan 03, 2017 | Sale | $11.12 | 27,273 | 303,289 | 102,200 | Jan 05, 2017, 05:14 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 23, 2016 | Option Exercise | $0.82 | 35,000 | 28,700 | 120,979 | Dec 27, 2016, 09:12 AM |
ISAACS STEPHEN T | President and CEO | Dec 01, 2016 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Dec 05, 2016, 07:23 PM |
ISAACS STEPHEN T | President and CEO | Dec 01, 2016 | Sale | $10.82 | 27,273 | 295,169 | 102,300 | Dec 05, 2016, 07:23 PM |
Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2016 | Option Exercise | $1.04 | 25,000 | 25,893 | 64,900 | Dec 05, 2016, 07:21 PM |
Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2016 | Sale | $10.94 | 25,000 | 273,500 | 39,900 | Dec 05, 2016, 07:21 PM |
Haghighat Ross | Director | Nov 14, 2016 | Sale | $15.50 | 7,088 | 109,864 | 81,880 | Nov 16, 2016, 09:19 PM |
ISAACS STEPHEN T | President and CEO | Nov 14, 2016 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Nov 16, 2016, 05:06 PM |
ISAACS STEPHEN T | President and CEO | Nov 14, 2016 | Sale | $15.26 | 27,273 | 416,050 | 102,200 | Nov 16, 2016, 05:06 PM |
Lew Jennifer | Sr. Vice President of Finance | Nov 10, 2016 | Option Exercise | $0.82 | 10,910 | 8,946 | 53,505 | Nov 14, 2016, 07:02 PM |
Lew Jennifer | Sr. Vice President of Finance | Nov 10, 2016 | Sale | $14.95 | 10,910 | 163,104 | 42,595 | Nov 14, 2016, 07:02 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 11, 2016 | Option Exercise | $1.45 | 30,144 | 43,709 | 116,123 | Nov 14, 2016, 07:01 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 10, 2016 | Option Exercise | $1.45 | 49,856 | 72,291 | 135,835 | Nov 14, 2016, 07:01 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 11, 2016 | Sale | $14.86 | 30,144 | 448,033 | 85,979 | Nov 14, 2016, 07:01 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 10, 2016 | Sale | $14.74 | 49,856 | 734,698 | 85,979 | Nov 14, 2016, 07:01 PM |
Dubensky Thomas W. | Chief Scientific Officer | Nov 10, 2016 | Option Exercise | $1.30 | 25,000 | 32,588 | 64,900 | Nov 14, 2016, 07:00 PM |
Dubensky Thomas W. | Chief Scientific Officer | Nov 10, 2016 | Sale | $14.78 | 25,000 | 369,408 | 39,900 | Nov 14, 2016, 07:00 PM |
ISAACS STEPHEN T | President and CEO | Oct 03, 2016 | Option Exercise | $0.52 | 27,273 | 14,182 | 129,473 | Oct 05, 2016, 05:22 PM |
ISAACS STEPHEN T | President and CEO | Oct 03, 2016 | Sale | $12.67 | 27,273 | 345,522 | 102,200 | Oct 05, 2016, 05:22 PM |
Dubensky Thomas W. | Chief Scientific Officer | Oct 03, 2016 | Option Exercise | $1.10 | 25,000 | 27,437 | 64,900 | Oct 05, 2016, 05:18 PM |
Dubensky Thomas W. | Chief Scientific Officer | Oct 03, 2016 | Sale | $12.68 | 25,000 | 316,908 | 39,900 | Oct 05, 2016, 05:18 PM |
Lew Jennifer | Sr. Vice President of Finance | Sep 19, 2016 | Option Exercise | $0.82 | 5,455 | 4,473 | 48,955 | Sep 21, 2016, 04:57 PM |
Lew Jennifer | Sr. Vice President of Finance | Sep 19, 2016 | Sale | $14.95 | 6,360 | 95,082 | 42,595 | Sep 21, 2016, 04:57 PM |
Dubensky Thomas W. | Chief Scientific Officer | Sep 01, 2016 | Option Exercise | $1.13 | 25,000 | 28,259 | 25,000 | Sep 02, 2016, 04:24 PM |
Dubensky Thomas W. | Chief Scientific Officer | Sep 01, 2016 | Sale | $14.03 | 25,000 | 350,775 | 0 | Sep 02, 2016, 04:24 PM |
Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2016 | Option Exercise | $0.99 | 25,000 | 24,625 | 25,000 | Aug 12, 2016, 05:43 PM |
Dubensky Thomas W. | Chief Scientific Officer | Aug 11, 2016 | Sale | $15.18 | 25,000 | 379,500 | 0 | Aug 12, 2016, 05:43 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2016 | Option Exercise | $1.04 | 25,000 | 25,963 | 25,000 | Jul 07, 2016, 06:38 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jul 05, 2016 | Sale | $11.61 | 25,000 | 290,250 | 0 | Jul 07, 2016, 06:38 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | May 16, 2016 | Sale | $8.20 | 905 | 7,421 | 12,000 | May 18, 2016, 07:14 PM |
SCHAFER GREGORY W | Chief Operating Officer | May 16, 2016 | Sale | $8.20 | 905 | 7,421 | 49,279 | May 18, 2016, 07:13 PM |
Dubensky Thomas W. | Chief Scientific Officer | May 16, 2016 | Sale | $8.20 | 905 | 7,421 | 0 | May 18, 2016, 07:11 PM |
Morningside Venture (VI) Investments Ltd | 10% Owner | Feb 18, 2016 | Option Exercise | $0.10 | 762,014 | 76,097 | 19,805,532 | Feb 22, 2016, 05:59 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Jan 11, 2016 | Option Exercise | $0.49 | 22,000 | 10,856 | 33,044 | Jan 11, 2016, 08:35 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Jan 11, 2016 | Sale | $21.77 | 22,000 | 479,015 | 14,406 | Jan 11, 2016, 08:35 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jan 08, 2016 | Option Exercise | $1.00 | 20,000 | 20,000 | 69,279 | Jan 11, 2016, 08:33 PM |
SCHAFER GREGORY W | Chief Operating Officer | Jan 08, 2016 | Sale | $23.58 | 20,000 | 471,600 | 49,279 | Jan 11, 2016, 08:33 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jan 04, 2016 | Option Exercise | $4.68 | 15,000 | 70,158 | 15,000 | Jan 06, 2016, 06:18 PM |
Dubensky Thomas W. | Chief Scientific Officer | Jan 04, 2016 | Sale | $26.37 | 15,000 | 395,531 | 3,771 | Jan 06, 2016, 06:18 PM |
ISAACS STEPHEN T | President and CEO | Jan 04, 2016 | Option Exercise | $0.52 | 12,500 | 6,500 | 22,500 | Jan 06, 2016, 06:16 PM |
ISAACS STEPHEN T | President and CEO | Jan 05, 2016 | Option Exercise | $0.52 | 12,500 | 6,500 | 22,500 | Jan 06, 2016, 06:16 PM |
ISAACS STEPHEN T | President and CEO | Jan 05, 2016 | Sale | $26.26 | 12,500 | 328,196 | 10,906 | Jan 06, 2016, 06:16 PM |
ISAACS STEPHEN T | President and CEO | Jan 04, 2016 | Sale | $26.37 | 12,500 | 329,603 | 10,300 | Jan 06, 2016, 06:16 PM |
Lew Jennifer | Sr. Vice President of Finance | Jan 06, 2016 | Option Exercise | $0.82 | 5,242 | 4,298 | 11,442 | Jan 06, 2016, 06:13 PM |
Lew Jennifer | Sr. Vice President of Finance | Jan 06, 2016 | Sale | $25.71 | 5,242 | 134,765 | 7,000 | Jan 06, 2016, 06:13 PM |
ISAACS STEPHEN T | President and CEO | Dec 31, 2015 | Option Exercise | $0.45 | 10,000 | 4,500 | 10,000 | Jan 04, 2016, 07:04 PM |
Lew Jennifer | Sr. Vice President of Finance | Dec 29, 2015 | Option Exercise | $0.82 | 4,200 | 3,444 | 6,200 | Dec 29, 2015, 06:11 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 24, 2015 | Option Exercise | $0.82 | 15,000 | 12,300 | 49,279 | Dec 28, 2015, 07:22 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Dec 16, 2015 | Option Exercise | $1.45 | 12,000 | 17,400 | 12,000 | Dec 17, 2015, 07:06 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Dec 10, 2015 | Option Exercise | $1.45 | 25,000 | 36,250 | 25,000 | Dec 14, 2015, 06:42 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Dec 10, 2015 | Sale | $29.82 | 25,000 | 745,423 | 19,265 | Dec 14, 2015, 06:42 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 07, 2015 | Option Exercise | $1.45 | 25,000 | 36,250 | 59,279 | Dec 07, 2015, 07:40 PM |
SCHAFER GREGORY W | Chief Operating Officer | Dec 07, 2015 | Sale | $29.74 | 25,000 | 743,571 | 42,579 | Dec 07, 2015, 07:40 PM |
Lew Jennifer | Sr. Vice President of Finance | Dec 03, 2015 | Option Exercise | $0.82 | 5,242 | 4,298 | 7,242 | Dec 07, 2015, 07:32 PM |
Lew Jennifer | Sr. Vice President of Finance | Dec 03, 2015 | Sale | $29.85 | 5,242 | 156,486 | 2,100 | Dec 07, 2015, 07:32 PM |
ISAACS STEPHEN T | President and CEO | Dec 01, 2015 | Option Exercise | $0.52 | 25,000 | 13,000 | 25,000 | Dec 02, 2015, 06:26 PM |
ISAACS STEPHEN T | President and CEO | Dec 01, 2015 | Sale | $29.11 | 25,000 | 727,664 | 2,200 | Dec 02, 2015, 06:26 PM |
Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2015 | Option Exercise | $2.15 | 30,000 | 64,373 | 30,000 | Dec 02, 2015, 06:24 PM |
Dubensky Thomas W. | Chief Scientific Officer | Dec 01, 2015 | Sale | $29.27 | 30,000 | 878,104 | 9,626 | Dec 02, 2015, 06:24 PM |
Greenman William Mariner | Director | Nov 30, 2015 | Sale | $30.65 | 3,000 | 91,950 | 0 | Dec 02, 2015, 06:21 PM |
Lew Jennifer | Sr. Vice President of Finance | Nov 18, 2015 | Option Exercise | $0.82 | 5,242 | 4,298 | 8,712 | Nov 18, 2015, 08:30 PM |
Lew Jennifer | Sr. Vice President of Finance | Nov 18, 2015 | Sale | $28.52 | 6,712 | 191,426 | 3,470 | Nov 18, 2015, 08:30 PM |
ISAACS STEPHEN T | President and CEO | Nov 16, 2015 | Option Exercise | $0.52 | 25,000 | 13,000 | 25,000 | Nov 18, 2015, 08:27 PM |
ISAACS STEPHEN T | President and CEO | Nov 16, 2015 | Sale | $27.54 | 25,000 | 688,490 | 2,700 | Nov 18, 2015, 08:27 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 17, 2015 | Option Exercise | $0.69 | 19,047 | 13,220 | 19,047 | Nov 18, 2015, 08:24 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 16, 2015 | Option Exercise | $0.45 | 5,953 | 2,679 | 7,423 | Nov 18, 2015, 08:24 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 17, 2015 | Sale | $28.65 | 19,047 | 545,734 | 16,947 | Nov 18, 2015, 08:24 PM |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | Nov 16, 2015 | Sale | $27.52 | 7,423 | 204,294 | 1,470 | Nov 18, 2015, 08:24 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 16, 2015 | Option Exercise | $1.45 | 9,822 | 14,242 | 45,571 | Nov 18, 2015, 08:21 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 17, 2015 | Option Exercise | $1.45 | 15,178 | 22,008 | 49,457 | Nov 18, 2015, 08:21 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 16, 2015 | Sale | $27.56 | 11,292 | 311,168 | 36,349 | Nov 18, 2015, 08:21 PM |
SCHAFER GREGORY W | Chief Operating Officer | Nov 17, 2015 | Sale | $28.60 | 15,178 | 434,072 | 46,849 | Nov 18, 2015, 08:21 PM |
Dubensky Thomas W. | Chief Scientific Officer | Nov 17, 2015 | Option Exercise | $1.45 | 20,519 | 29,753 | 20,519 | Nov 18, 2015, 08:11 PM |
Dubensky Thomas W. | Chief Scientific Officer | Nov 16, 2015 | Option Exercise | $1.45 | 9,481 | 13,747 | 10,951 | Nov 18, 2015, 08:11 PM |
Dubensky Thomas W. | Chief Scientific Officer | Nov 17, 2015 | Sale | $28.65 | 20,519 | 587,822 | 18,520 | Nov 18, 2015, 08:11 PM |
Dubensky Thomas W. | Chief Scientific Officer | Nov 16, 2015 | Sale | $27.55 | 10,951 | 301,733 | 2,170 | Nov 18, 2015, 08:11 PM |
ISAACS STEPHEN T | President and CEO | Jul 24, 2015 | Option Exercise | $0.05 | 11,916 | 609 | 154,687 | Jul 27, 2015, 06:51 PM |
Rogers John E. and Lois A. | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 7,500 | 127,500 | 33,649 | Apr 22, 2015, 05:50 PM |
Rogers John E. and Lois A. | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 10,000 | 170,000 | 36,149 | Apr 22, 2015, 05:50 PM |
Rogers John E. and Lois A. | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 147,058 | 2,499,986 | 5,991,759 | Apr 22, 2015, 05:49 PM |
Morningside Venture (VI) Investments Ltd | 10% Owner | Apr 20, 2015 | Buy | $17.00 | 441,176 | 7,499,992 | 19,043,518 | Apr 22, 2015, 05:46 PM |
OBrien Stephanie Monaghan | Director | Apr 20, 2015 | Buy | $17.00 | 1,700 | 28,900 | 1,700 | Apr 22, 2015, 05:45 PM |
OBrien Stephanie Monaghan | Director | Apr 20, 2015 | Buy | $17.00 | 1,700 | 28,900 | 1,700 | Apr 22, 2015, 05:45 PM |
Greenman William Mariner | Director | Apr 20, 2015 | Buy | $17.00 | 3,000 | 51,000 | 3,000 | Apr 22, 2015, 05:43 PM |
Lew Jennifer | Sr. Vice President of Finance | Apr 20, 2015 | Buy | $17.00 | 2,000 | 34,000 | 2,000 | Apr 22, 2015, 05:41 PM |
Owner | Relationship | Date | Value($) |
King Andrew James | Chief Scientific Officer | 08/01/2023 | 45,586 |
Greenman William Mariner | Director | 05/30/2023 | 26,911 |
DOBMEIER ERIC | President, CEO | 04/24/2023 | 10,500 |
DOBMEIER ERIC | President, CEO | 04/24/2023 | 540,239 |
Jerel Davis | Director | 04/17/2023 | 6,138,223 |
King Andrew James | Chief Scientific Officer | 04/03/2023 | 875 |
King Andrew James | Chief Scientific Officer | 04/03/2023 | 116,718 |
Krishnan Mahesh | Director | 04/04/2023 | 21,261 |
Jerel Davis | Director | 03/01/2023 | 9,100,000 |
BJERKHOLT ERIC | Chief Financial Officer | 02/10/2023 | 20,352 |
DOBMEIER ERIC | President, CEO | 02/10/2023 | 192,292 |
Frohlich Tom | Chief Operating Officer | 02/10/2023 | 87,869 |
King Andrew James | Chief Scientific Officer | 02/10/2023 | 56,806 |
Frohlich Tom | Chief Operating Officer | 01/31/2023 | 112,700 |
BJERKHOLT ERIC | Chief Financial Officer | 01/31/2023 | 71,357 |
King Andrew James | Chief Scientific Officer | 01/31/2023 | 80,069 |
DOBMEIER ERIC | President, CEO | 01/30/2023 | 10,500 |
DOBMEIER ERIC | President, CEO | 01/31/2023 | 189,757 |
DOBMEIER ERIC | President, CEO | 01/30/2023 | 613,613 |
King Andrew James | Chief Scientific Officer | 01/03/2023 | 2,625 |
King Andrew James | Chief Scientific Officer | 01/03/2023 | 258,183 |
Frohlich Tom | Chief Operating Officer | 12/13/2022 | 4,200 |
Frohlich Tom | Chief Operating Officer | 12/13/2022 | 250,005 |
DOBMEIER ERIC | President, CEO | 12/14/2022 | 10,500 |
DOBMEIER ERIC | President, CEO | 12/01/2022 | 25,200 |
DOBMEIER ERIC | President, CEO | 12/01/2022 | 669,351 |
BJERKHOLT ERIC | Chief Financial Officer | 12/01/2022 | 128,602 |
Frohlich Tom | Chief Operating Officer | 11/07/2022 | 4,200 |
Frohlich Tom | Chief Operating Officer | 11/07/2022 | 221,642 |
Frohlich Tom | Chief Operating Officer | 10/06/2022 | 144,933 |
King Andrew James | Chief Scientific Officer | 10/06/2022 | 70,044 |
Thomas Dolca | Director | 09/02/2022 | 212,194 |
King Andrew James | Chief Scientific Officer | 08/04/2022 | 1,750 |
King Andrew James | Chief Scientific Officer | 08/04/2022 | 100,000 |
King Andrew James | Chief Scientific Officer | 07/11/2022 | 1,750 |
King Andrew James | Chief Scientific Officer | 07/11/2022 | 90,468 |
AKKARAJU SRINIVAS | Director | 05/27/2022 | 7,980,000 |
DOBMEIER ERIC | President, CEO | 05/25/2022 | 65,148 |
King Andrew James | Chief Scientific Officer | 04/11/2022 | 1,750 |
King Andrew James | Chief Scientific Officer | 04/11/2022 | 76,812 |
King Andrew James | Chief Scientific Officer | 02/18/2022 | 32,500 |
BJERKHOLT ERIC | Chief Financial Officer | 02/11/2022 | 11,403 |
King Andrew James | Chief Scientific Officer | 02/11/2022 | 31,827 |
Glicklich Alan | Chief Medical Officer | 02/11/2022 | 30,464 |
Frohlich Tom | Chief Operating Officer | 02/11/2022 | 47,587 |
King Andrew James | Chief Scientific Officer | 02/10/2022 | 875 |
King Andrew James | Chief Scientific Officer | 02/10/2022 | 33,275 |
Versant Venture Capital VII, L.P. | 10% Owner | 01/03/2022 | 6,400,080 |
Versant Venture Capital VII, L.P. | 10% Owner | 01/03/2022 | 9,600,120 |
Jerel Davis | Director | 01/03/2022 | 16,000,200 |
DOBMEIER ERIC | President, CEO | 12/23/2021 | 14,000 |
BJERKHOLT ERIC | Chief Financial Officer | 12/01/2021 | 92,097 |
AKKARAJU SRINIVAS | Director | 11/15/2021 | 17,010,000 |
Frohlich Tom | Chief Operating Officer | 11/10/2021 | 96,440 |
King Andrew James | Chief Scientific Officer | 11/09/2021 | 875 |
King Andrew James | Chief Scientific Officer | 11/09/2021 | 67,660 |
Frohlich Tom | Chief Operating Officer | 11/05/2021 | 6,300 |
Frohlich Tom | Chief Operating Officer | 11/05/2021 | 280,000 |
Frohlich Tom | Chief Operating Officer | 11/08/2021 | 208,938 |
Greenman William Mariner | Director | 10/21/2021 | 4,324 |
Frohlich Tom | Chief Operating Officer | 10/06/2021 | 91,021 |
King Andrew James | Chief Scientific Officer | 10/06/2021 | 43,995 |
Glicklich Alan | Chief Medical Officer | 10/06/2021 | 30,785 |
Frohlich Tom | Chief Operating Officer | 09/24/2021 | 8,400 |
Frohlich Tom | Chief Operating Officer | 09/24/2021 | 260,000 |
DOBMEIER ERIC | President, CEO | 09/20/2021 | 24,000 |
Jerel Davis | Director | 08/27/2021 | 11,900,000 |
Versant Venture Capital VII, L.P. | 10% Owner | 08/27/2021 | 4,760,000 |
Versant Venture Capital VII, L.P. | 10% Owner | 08/27/2021 | 7,140,000 |
AKKARAJU SRINIVAS | Director | 08/18/2021 | 2,497,830 |
DOBMEIER ERIC | President, CEO | 08/19/2021 | 36,000 |
DOBMEIER ERIC | President, CEO | 08/18/2021 | 82,163 |
Glicklich Alan | Chief Medical Officer | 06/16/2021 | 8,400 |
Glicklich Alan | Chief Medical Officer | 06/16/2021 | 326,968 |
DOBMEIER ERIC | President, CEO | 06/14/2021 | 7,000 |
DOBMEIER ERIC | President, CEO | 12/21/2020 | 7,000 |
DOBMEIER ERIC | President, CEO | 12/09/2020 | 26,150 |
DOBMEIER ERIC | President, CEO | 12/08/2020 | 26,483 |
DOBMEIER ERIC | President, CEO | 11/23/2020 | 12,699 |
DOBMEIER ERIC | President, CEO | 11/20/2020 | 7,817 |
DOBMEIER ERIC | President, CEO | 11/19/2020 | 6,750 |
DOBMEIER ERIC | President, CEO | 11/11/2020 | 34,375 |
DOBMEIER ERIC | President, CEO | 11/10/2020 | 27,720 |
ISAACS STEPHEN T | President and CEO | 09/15/2020 | 77,691 |
Templeman Blaine | Chief Legal Officer | 09/15/2020 | 29,585 |
Ferber Celeste | SVP, GC and Secretary | 09/15/2020 | 5,731 |
Nuyten Dimitry SA | Chief Medical Officer | 08/07/2020 | 9,036 |
Templeman Blaine | Chief Legal Officer | 08/07/2020 | 20,308 |
Ferber Celeste | SVP, GC and Secretary | 08/07/2020 | 20,308 |
Greenman William Mariner | Director | 03/18/2020 | 8,926 |
ISAACS STEPHEN T | President and CEO | 03/18/2020 | 9,728 |
van Elsas Andrea | Chief Scientific Officer | 02/25/2020 | 23,954 |
van Elsas Andrea | Chief Scientific Officer | 01/03/2020 | 87,108 |
Templeman Blaine | Chief Legal Officer | 12/12/2019 | 1,470 |
Ferber Celeste | SVP, GC and Secretary | 12/12/2019 | 475 |
van Elsas Andrea | Chief Scientific Officer | 12/12/2019 | 2,550 |
ISAACS STEPHEN T | President and CEO | 12/12/2019 | 6,860 |
Haghighat Ross | Director | 09/16/2019 | 35,527 |
Ferber Celeste | SVP, GC and Secretary | 09/13/2019 | 3,257 |
ISAACS STEPHEN T | President and CEO | 09/13/2019 | 40,608 |
van Elsas Andrea | Chief Scientific Officer | 09/13/2019 | 24,279 |
Templeman Blaine | Chief Legal Officer | 09/13/2019 | 16,817 |
Ferber Celeste | SVP, GC and Secretary | 05/20/2019 | 6,413 |
Lew Jennifer | Chief Financial Officer | 05/01/2019 | 23,306 |
Lew Jennifer | Chief Financial Officer | 05/01/2019 | 78,136 |
Lew Jennifer | Chief Financial Officer | 04/08/2019 | 23,305 |
Lew Jennifer | Chief Financial Officer | 04/08/2019 | 75,775 |
van Elsas Andrea | Chief Scientific Officer | 03/19/2019 | 24,107 |
van Elsas Andrea | Chief Scientific Officer | 02/26/2019 | 29,120 |
van Elsas Andrea | Chief Scientific Officer | 12/28/2018 | 4,901 |
Lew Jennifer | Chief Financial Officer | 12/12/2018 | 3,035 |
Templeman Blaine | Chief Legal Officer | 12/12/2018 | 3,639 |
ISAACS STEPHEN T | President and CEO | 12/12/2018 | 17,091 |
van Elsas Andrea | Chief Scientific Officer | 12/12/2018 | 6,365 |
Templeman Blaine | Chief Legal Officer | 11/20/2018 | 2,453 |
van Elsas Andrea | Chief Scientific Officer | 09/24/2018 | 45,022 |
Templeman Blaine | Chief Legal Officer | 09/24/2018 | 59,613 |
Templeman Blaine | Executive VP, General Counsel | 09/13/2018 | 39,360 |
van Elsas Andrea | Chief Scientific Officer | 09/13/2018 | 63,394 |
Lew Jennifer | Chief Financial Officer | 09/13/2018 | 36,546 |
Sacks Natalie | Chief Medical Officer | 09/13/2018 | 19,680 |
ISAACS STEPHEN T | President and CEO | 09/13/2018 | 156,913 |
ISAACS STEPHEN T | President and CEO | 09/06/2018 | 46,987 |
ISAACS STEPHEN T | President and CEO | 09/05/2018 | 15,585 |
ISAACS STEPHEN T | President and CEO | 09/06/2018 | 372,024 |
ISAACS STEPHEN T | President and CEO | 09/05/2018 | 123,134 |
Sacks Natalie | Chief Medical Officer | 09/04/2018 | 32,099 |
van Elsas Andrea | Chief Scientific Officer | 07/17/2018 | 72,803 |
ISAACS STEPHEN T | President and CEO | 06/01/2018 | 40,000 |
ISAACS STEPHEN T | President and CEO | 06/01/2018 | 347,004 |
Templeman Blaine | Chief Legal Officer | 05/17/2018 | 16,300 |
ISAACS STEPHEN T | President and CEO | 05/09/2018 | 38,976 |
ISAACS STEPHEN T | President and CEO | 05/09/2018 | 320,348 |
ISAACS STEPHEN T | President and CEO | 04/02/2018 | 32,800 |
ISAACS STEPHEN T | President and CEO | 04/02/2018 | 356,400 |
ISAACS STEPHEN T | President and CEO | 03/09/2018 | 23,165 |
ISAACS STEPHEN T | President and CEO | 03/08/2018 | 11,535 |
ISAACS STEPHEN T | President and CEO | 03/09/2018 | 407,268 |
ISAACS STEPHEN T | President and CEO | 03/08/2018 | 203,790 |
van Elsas Andrea | Chief Scientific Officer | 02/26/2018 | 44,522 |
SCHAFER GREGORY W | Chief Operating Officer | 01/25/2018 | 49,200 |
SCHAFER GREGORY W | Chief Operating Officer | 01/25/2018 | 33 |
ISAACS STEPHEN T | President and CEO | 01/05/2018 | 3,577 |
ISAACS STEPHEN T | President and CEO | 01/05/2018 | 63,195 |
Brockstedt Dirk G. | EVP of Research and Dev. | 12/29/2017 | 75,400 |
SCHAFER GREGORY W | Chief Operating Officer | 01/02/2018 | 20,767 |
SCHAFER GREGORY W | Chief Operating Officer | 12/29/2017 | 34,440 |
SCHAFER GREGORY W | Chief Operating Officer | 01/02/2018 | 152,142 |
Templeman Blaine | Executive VP, General Counsel | 12/18/2017 | 23,793 |
Brockstedt Dirk G. | EVP of Research and Dev. | 12/15/2017 | 92,957 |
Brockstedt Dirk G. | EVP of Research and Dev. | 12/15/2017 | 529,187 |
van Elsas Andrea | Chief Scientific Officer | 09/13/2017 | 54,072 |
Brockstedt Dirk G. | EVP of Research and Dev. | 12/01/2017 | 5,200 |
Brockstedt Dirk G. | EVP of Research and Dev. | 12/01/2017 | 93,998 |
Lew Jennifer | Sr. Vice President of Finance | 12/01/2017 | 5,412 |
Lew Jennifer | Sr. Vice President of Finance | 12/01/2017 | 62,433 |
SCHAFER GREGORY W | Chief Operating Officer | 12/01/2017 | 20,767 |
SCHAFER GREGORY W | Chief Operating Officer | 12/01/2017 | 186,882 |
ISAACS STEPHEN T | President and CEO | 12/01/2017 | 18,000 |
ISAACS STEPHEN T | President and CEO | 12/01/2017 | 375,028 |
Templeman Blaine | Executive VP, General Counsel | 11/17/2017 | 2,151 |
Lew Jennifer | Sr. Vice President of Finance | 11/15/2017 | 5,412 |
Lew Jennifer | Sr. Vice President of Finance | 11/15/2017 | 59,070 |
ISAACS STEPHEN T | President and CEO | 11/13/2017 | 1,530 |
ISAACS STEPHEN T | President and CEO | 11/10/2017 | 7,380 |
ISAACS STEPHEN T | President and CEO | 11/13/2017 | 27,215 |
ISAACS STEPHEN T | President and CEO | 11/10/2017 | 130,508 |
Brockstedt Dirk G. | EVP of Research and Dev. | 11/13/2017 | 2,112 |
Brockstedt Dirk G. | EVP of Research and Dev. | 11/10/2017 | 944 |
Brockstedt Dirk G. | EVP of Research and Dev. | 11/13/2017 | 32,496 |
Brockstedt Dirk G. | EVP of Research and Dev. | 11/10/2017 | 14,544 |
SCHAFER GREGORY W | Chief Operating Officer | 11/06/2017 | 20,767 |
SCHAFER GREGORY W | Chief Operating Officer | 11/06/2017 | 159,312 |
Brockstedt Dirk G. | EVP of Research and Dev. | 11/06/2017 | 2,144 |
Brockstedt Dirk G. | EVP of Research and Dev. | 11/06/2017 | 33,132 |
ISAACS STEPHEN T | President and CEO | 11/07/2017 | 1,710 |
ISAACS STEPHEN T | President and CEO | 11/06/2017 | 7,380 |
ISAACS STEPHEN T | President and CEO | 11/07/2017 | 30,223 |
ISAACS STEPHEN T | President and CEO | 11/06/2017 | 130,934 |
Brockstedt Dirk G. | EVP of Research and Dev. | 10/02/2017 | 5,200 |
Brockstedt Dirk G. | EVP of Research and Dev. | 10/02/2017 | 105,870 |
SCHAFER GREGORY W | Chief Operating Officer | 10/02/2017 | 27,148 |
SCHAFER GREGORY W | Chief Operating Officer | 10/02/2017 | 215,060 |
ISAACS STEPHEN T | President and CEO | 10/02/2017 | 18,000 |
ISAACS STEPHEN T | President and CEO | 10/02/2017 | 431,032 |
Lew Jennifer | Sr. Vice President of Finance | 10/02/2017 | 5,412 |
Lew Jennifer | Sr. Vice President of Finance | 10/02/2017 | 69,995 |
Templeman Blaine | Executive VP, General Counsel | 09/18/2017 | 32,301 |
ISAACS STEPHEN T | President and CEO | 09/13/2017 | 134,071 |
SCHAFER GREGORY W | Chief Operating Officer | 09/13/2017 | 53,380 |
Brockstedt Dirk G. | EVP of Research and Dev. | 09/13/2017 | 39,076 |
Lew Jennifer | Sr. Vice President of Finance | 09/13/2017 | 39,076 |
van Elsas Andrea | Chief Scientific Officer | 09/13/2017 | 54,072 |
Templeman Blaine | Executive VP, General Counsel | 09/13/2017 | 39,076 |
Sacks Natalie | Chief Medical Officer | 09/01/2017 | 57,196 |
SCHAFER GREGORY W | Chief Operating Officer | 09/01/2017 | 24,800 |
SCHAFER GREGORY W | Chief Operating Officer | 09/01/2017 | 233,980 |
Lew Jennifer | Sr. Vice President of Finance | 09/01/2017 | 5,412 |
Lew Jennifer | Sr. Vice President of Finance | 09/01/2017 | 77,242 |
ISAACS STEPHEN T | President and CEO | 09/01/2017 | 18,000 |
ISAACS STEPHEN T | President and CEO | 09/01/2017 | 468,596 |
Brockstedt Dirk G. | EVP of Research and Dev. | 09/01/2017 | 5,200 |
Brockstedt Dirk G. | EVP of Research and Dev. | 09/01/2017 | 116,948 |
Dubensky Thomas W. | Chief Scientific Officer | 08/10/2017 | 40,912 |
Dubensky Thomas W. | Chief Scientific Officer | 08/11/2017 | 9,088 |
Dubensky Thomas W. | Chief Scientific Officer | 08/11/2017 | 101,538 |
Dubensky Thomas W. | Chief Scientific Officer | 08/10/2017 | 467,665 |
ISAACS STEPHEN T | President and CEO | 08/07/2017 | 18,000 |
ISAACS STEPHEN T | President and CEO | 08/07/2017 | 487,564 |
SCHAFER GREGORY W | Chief Operating Officer | 08/07/2017 | 31,616 |
SCHAFER GREGORY W | Chief Operating Officer | 08/08/2017 | 18,004 |
SCHAFER GREGORY W | Chief Operating Officer | 08/08/2017 | 172,550 |
SCHAFER GREGORY W | Chief Operating Officer | 08/07/2017 | 314,233 |
Brockstedt Dirk G. | EVP of Research and Dev. | 08/07/2017 | 5,200 |
Brockstedt Dirk G. | EVP of Research and Dev. | 08/07/2017 | 121,795 |
Lew Jennifer | Sr. Vice President of Finance | 08/07/2017 | 5,412 |
Lew Jennifer | Sr. Vice President of Finance | 08/07/2017 | 80,290 |
Lew Jennifer | Sr. Vice President of Finance | 07/03/2017 | 9,840 |
Lew Jennifer | Sr. Vice President of Finance | 07/03/2017 | 133,632 |
ISAACS STEPHEN T | President and CEO | 07/03/2017 | 19,965 |
ISAACS STEPHEN T | President and CEO | 07/05/2017 | 14,763 |
ISAACS STEPHEN T | President and CEO | 07/03/2017 | 427,634 |
Brockstedt Dirk G. | EVP of Research and Dev. | 07/03/2017 | 4,826 |
Brockstedt Dirk G. | EVP of Research and Dev. | 07/03/2017 | 110,167 |
Dubensky Thomas W. | Chief Scientific Officer | 07/05/2017 | 17,518 |
Dubensky Thomas W. | Chief Scientific Officer | 07/03/2017 | 6,136 |
Dubensky Thomas W. | Chief Scientific Officer | 07/06/2017 | 2,346 |
Dubensky Thomas W. | Chief Scientific Officer | 07/05/2017 | 385,936 |
Dubensky Thomas W. | Chief Scientific Officer | 07/03/2017 | 130,028 |
Dubensky Thomas W. | Chief Scientific Officer | 07/06/2017 | 50,673 |
Lew Jennifer | Sr. Vice President of Finance | 06/28/2017 | 9,840 |
Lew Jennifer | Sr. Vice President of Finance | 06/28/2017 | 134,236 |
SCHAFER GREGORY W | Chief Operating Officer | 06/28/2017 | 58,000 |
SCHAFER GREGORY W | Chief Operating Officer | 06/28/2017 | 450,568 |
ISAACS STEPHEN T | President and CEO | 06/19/2017 | 20,800 |
ISAACS STEPHEN T | President and CEO | 06/19/2017 | 420,164 |
Dubensky Thomas W. | Chief Scientific Officer | 06/05/2017 | 9,140 |
Dubensky Thomas W. | Chief Scientific Officer | 06/02/2017 | 25,352 |
Dubensky Thomas W. | Chief Scientific Officer | 06/01/2017 | 40,545 |
Dubensky Thomas W. | Chief Scientific Officer | 06/02/2017 | 492,283 |
Dubensky Thomas W. | Chief Scientific Officer | 06/01/2017 | 779,866 |
Dubensky Thomas W. | Chief Scientific Officer | 06/05/2017 | 175,628 |
Brockstedt Dirk G. | EVP of Research and Dev. | 06/01/2017 | 4,160 |
Brockstedt Dirk G. | EVP of Research and Dev. | 06/01/2017 | 80,020 |
Brockstedt Dirk G. | EVP of Research and Dev. | 05/17/2017 | 9,756 |
Templeman Blaine | Executive VP, General Counsel | 05/17/2017 | 15,903 |
ISAACS STEPHEN T | President and CEO | 05/16/2017 | 8,670 |
ISAACS STEPHEN T | President and CEO | 05/15/2017 | 5,512 |
ISAACS STEPHEN T | President and CEO | 05/16/2017 | 166,797 |
ISAACS STEPHEN T | President and CEO | 05/15/2017 | 106,154 |
Brockstedt Dirk G. | EVP of Research and Dev. | 05/11/2017 | 4,160 |
Brockstedt Dirk G. | EVP of Research and Dev. | 05/11/2017 | 77,725 |
Dubensky Thomas W. | Chief Scientific Officer | 05/12/2017 | 2,235 |
Dubensky Thomas W. | Chief Scientific Officer | 05/11/2017 | 728 |
Dubensky Thomas W. | Chief Scientific Officer | 05/12/2017 | 42,658 |
Dubensky Thomas W. | Chief Scientific Officer | 05/11/2017 | 13,870 |
Brockstedt Dirk G. | EVP of Research and Dev. | 04/03/2017 | 3,600 |
Brockstedt Dirk G. | EVP of Research and Dev. | 04/03/2017 | 85,645 |
ISAACS STEPHEN T | President and CEO | 04/03/2017 | 14,182 |
ISAACS STEPHEN T | President and CEO | 04/03/2017 | 280,429 |
ISAACS STEPHEN T | President and CEO | 03/13/2017 | 14,182 |
ISAACS STEPHEN T | President and CEO | 03/13/2017 | 309,434 |
Brockstedt Dirk G. | EVP of Research and Dev. | 03/09/2017 | 3,600 |
Brockstedt Dirk G. | EVP of Research and Dev. | 03/09/2017 | 88,001 |
Dubensky Thomas W. | Chief Scientific Officer | 03/09/2017 | 19,446 |
Dubensky Thomas W. | Chief Scientific Officer | 03/09/2017 | 274,078 |
Brockstedt Dirk G. | EVP of Research and Dev. | 01/17/2017 | 3,600 |
Brockstedt Dirk G. | EVP of Research and Dev. | 01/17/2017 | 94,858 |
Templeman Blaine | Executive VP, General Counsel | 01/11/2017 | 45,231 |
Dubensky Thomas W. | Chief Scientific Officer | 01/03/2017 | 13,000 |
Dubensky Thomas W. | Chief Scientific Officer | 01/03/2017 | 278,990 |
ISAACS STEPHEN T | President and CEO | 01/03/2017 | 14,182 |
ISAACS STEPHEN T | President and CEO | 01/03/2017 | 303,289 |
SCHAFER GREGORY W | Chief Operating Officer | 12/23/2016 | 28,700 |
ISAACS STEPHEN T | President and CEO | 12/01/2016 | 14,182 |
ISAACS STEPHEN T | President and CEO | 12/01/2016 | 295,169 |
Dubensky Thomas W. | Chief Scientific Officer | 12/01/2016 | 25,893 |
Dubensky Thomas W. | Chief Scientific Officer | 12/01/2016 | 273,500 |
Haghighat Ross | Director | 11/14/2016 | 109,864 |
ISAACS STEPHEN T | President and CEO | 11/14/2016 | 14,182 |
ISAACS STEPHEN T | President and CEO | 11/14/2016 | 416,050 |
Lew Jennifer | Sr. Vice President of Finance | 11/10/2016 | 8,946 |
Lew Jennifer | Sr. Vice President of Finance | 11/10/2016 | 163,104 |
SCHAFER GREGORY W | Chief Operating Officer | 11/11/2016 | 43,709 |
SCHAFER GREGORY W | Chief Operating Officer | 11/10/2016 | 72,291 |
SCHAFER GREGORY W | Chief Operating Officer | 11/11/2016 | 448,033 |
SCHAFER GREGORY W | Chief Operating Officer | 11/10/2016 | 734,698 |
Dubensky Thomas W. | Chief Scientific Officer | 11/10/2016 | 32,588 |
Dubensky Thomas W. | Chief Scientific Officer | 11/10/2016 | 369,408 |
ISAACS STEPHEN T | President and CEO | 10/03/2016 | 14,182 |
ISAACS STEPHEN T | President and CEO | 10/03/2016 | 345,522 |
Dubensky Thomas W. | Chief Scientific Officer | 10/03/2016 | 27,437 |
Dubensky Thomas W. | Chief Scientific Officer | 10/03/2016 | 316,908 |
Lew Jennifer | Sr. Vice President of Finance | 09/19/2016 | 4,473 |
Lew Jennifer | Sr. Vice President of Finance | 09/19/2016 | 95,082 |
Dubensky Thomas W. | Chief Scientific Officer | 09/01/2016 | 28,259 |
Dubensky Thomas W. | Chief Scientific Officer | 09/01/2016 | 350,775 |
Dubensky Thomas W. | Chief Scientific Officer | 08/11/2016 | 24,625 |
Dubensky Thomas W. | Chief Scientific Officer | 08/11/2016 | 379,500 |
Dubensky Thomas W. | Chief Scientific Officer | 07/05/2016 | 25,963 |
Dubensky Thomas W. | Chief Scientific Officer | 07/05/2016 | 290,250 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 05/16/2016 | 7,421 |
SCHAFER GREGORY W | Chief Operating Officer | 05/16/2016 | 7,421 |
Dubensky Thomas W. | Chief Scientific Officer | 05/16/2016 | 7,421 |
Morningside Venture (VI) Investments Ltd | 10% Owner | 02/18/2016 | 76,097 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 01/11/2016 | 10,856 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 01/11/2016 | 479,015 |
SCHAFER GREGORY W | Chief Operating Officer | 01/08/2016 | 20,000 |
SCHAFER GREGORY W | Chief Operating Officer | 01/08/2016 | 471,600 |
Dubensky Thomas W. | Chief Scientific Officer | 01/04/2016 | 70,158 |
Dubensky Thomas W. | Chief Scientific Officer | 01/04/2016 | 395,531 |
ISAACS STEPHEN T | President and CEO | 01/04/2016 | 6,500 |
ISAACS STEPHEN T | President and CEO | 01/05/2016 | 6,500 |
ISAACS STEPHEN T | President and CEO | 01/05/2016 | 328,196 |
ISAACS STEPHEN T | President and CEO | 01/04/2016 | 329,603 |
Lew Jennifer | Sr. Vice President of Finance | 01/06/2016 | 4,298 |
Lew Jennifer | Sr. Vice President of Finance | 01/06/2016 | 134,765 |
ISAACS STEPHEN T | President and CEO | 12/31/2015 | 4,500 |
Lew Jennifer | Sr. Vice President of Finance | 12/29/2015 | 3,444 |
SCHAFER GREGORY W | Chief Operating Officer | 12/24/2015 | 12,300 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 12/16/2015 | 17,400 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 12/10/2015 | 36,250 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 12/10/2015 | 745,423 |
SCHAFER GREGORY W | Chief Operating Officer | 12/07/2015 | 36,250 |
SCHAFER GREGORY W | Chief Operating Officer | 12/07/2015 | 743,571 |
Lew Jennifer | Sr. Vice President of Finance | 12/03/2015 | 4,298 |
Lew Jennifer | Sr. Vice President of Finance | 12/03/2015 | 156,486 |
ISAACS STEPHEN T | President and CEO | 12/01/2015 | 13,000 |
ISAACS STEPHEN T | President and CEO | 12/01/2015 | 727,664 |
Dubensky Thomas W. | Chief Scientific Officer | 12/01/2015 | 64,373 |
Dubensky Thomas W. | Chief Scientific Officer | 12/01/2015 | 878,104 |
Greenman William Mariner | Director | 11/30/2015 | 91,950 |
Lew Jennifer | Sr. Vice President of Finance | 11/18/2015 | 4,298 |
Lew Jennifer | Sr. Vice President of Finance | 11/18/2015 | 191,426 |
ISAACS STEPHEN T | President and CEO | 11/16/2015 | 13,000 |
ISAACS STEPHEN T | President and CEO | 11/16/2015 | 688,490 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/17/2015 | 13,220 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/16/2015 | 2,679 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/17/2015 | 545,734 |
Brockstedt Dirk G. | Sr. VP of Research and Dev. | 11/16/2015 | 204,294 |
SCHAFER GREGORY W | Chief Operating Officer | 11/16/2015 | 14,242 |
SCHAFER GREGORY W | Chief Operating Officer | 11/17/2015 | 22,008 |
SCHAFER GREGORY W | Chief Operating Officer | 11/16/2015 | 311,168 |
SCHAFER GREGORY W | Chief Operating Officer | 11/17/2015 | 434,072 |
Dubensky Thomas W. | Chief Scientific Officer | 11/17/2015 | 29,753 |
Dubensky Thomas W. | Chief Scientific Officer | 11/16/2015 | 13,747 |
Dubensky Thomas W. | Chief Scientific Officer | 11/17/2015 | 587,822 |
Dubensky Thomas W. | Chief Scientific Officer | 11/16/2015 | 301,733 |
ISAACS STEPHEN T | President and CEO | 07/24/2015 | 609 |
Rogers John E. and Lois A. | 10% Owner | 04/20/2015 | 127,500 |
Rogers John E. and Lois A. | 10% Owner | 04/20/2015 | 170,000 |
Rogers John E. and Lois A. | 10% Owner | 04/20/2015 | 2,499,986 |
Morningside Venture (VI) Investments Ltd | 10% Owner | 04/20/2015 | 7,499,992 |
OBrien Stephanie Monaghan | Director | 04/20/2015 | 28,900 |
OBrien Stephanie Monaghan | Director | 04/20/2015 | 28,900 |
Greenman William Mariner | Director | 04/20/2015 | 51,000 |
Lew Jennifer | Sr. Vice President of Finance | 04/20/2015 | 34,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
FISHER ASSET MANAGEMENT, LLC | 22,820 | 0.00048% | Exited | Other |
Period of Report: 06/30/2023
10-K/10-Q Filings: View